Tri Locum Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-41,292
Closed -$1.31M 88
2023
Q2
$1.31M Buy
+41,292
New +$1.31M 0.49% 34